Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: DocMorris AG

Market Cap 412M 512M 446M 387M 723M 48.29B 729M 4.9B 1.9B 23.77B 1.92B 1.88B 82.55B P/E 2026 *
-5.33x
P/E 2027 * -9.58x
Enterprise Value 614M 762M 665M 577M 1.08B 71.96B 1.09B 7.3B 2.83B 35.42B 2.86B 2.8B 123B EV / Sales 2026 *
0.5x
EV / Sales 2027 * 0.48x
Free-Float
66.94%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 61 2022-04-27
Director of Finance/CFO 56 2024-09-30
Chief Tech/Sci/R&D Officer - 2024-10-31
Director TitleAgeSince
Chairman 68 2022-04-27
Director/Board Member 53 2019-05-22
Director/Board Member 56 2020-12-31
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 521M
-0.90%-7.58%-16.63%-35.60% 14.44B
-1.79%-5.17%-29.94%-36.17% 6.93B
-0.06%-2.07%-17.27%-14.72% 5.74B
+0.61%-5.82%-18.74%-37.12% 3.55B
-0.33%-0.85%-34.84%-13.22% 3.37B
-1.24%+0.16%-24.09%-45.68% 3.35B
-2.28%+1.05%+115.61% - 2.75B
+0.50%-1.82%+1.25%-44.00% 2.71B
-2.92%-3.44%-18.06%-4.47% 2.58B
Average -0.84%-2.91%-4.74%-28.87% 5.05B
Weighted average by Cap. -0.90%-3.89%-11.82%-30.68%

Financials

2026 *2027 *
Net sales 1.22B 1.51B 1.32B 1.15B 2.14B 143B 2.16B 14.49B 5.62B 70.28B 5.68B 5.56B 244B 1.37B 1.7B 1.48B 1.29B 2.4B 160B 2.42B 16.28B 6.31B 78.97B 6.38B 6.25B 274B
Net income -84.17M -105M -91.24M -79.2M -148M -9.87B -149M -1B -389M -4.86B -393M -384M -16.88B -48.29M -60M -52.34M -45.43M -84.78M -5.66B -85.51M -575M -223M -2.79B -225M -221M -9.68B
Net Debt 202M 251M 219M 190M 354M 23.67B 357M 2.4B 932M 11.65B 942M 922M 40.46B 241M 299M 261M 226M 423M 28.23B 426M 2.87B 1.11B 13.89B 1.12B 1.1B 48.26B
Logo DocMorris AG
DocMorris AG, formerly Zur Rose Group AG, is a Switzerland-based company engaged in the drug distribution sector. The Company focuses on the wholesale trade of medicines, as well as operation of a mail-order pharmacy. DocMorris operates at the healthcare, technology and e-commerce, with a primary focus on customer-centric digital healthcare and improving medication efficacy. core business is online pharmacy. In addition to prescription medicines (Rx), assortment features over-the-counter (OTC) and consumer health as well as beauty and personal care (BPC) products. Private labels, including nutritional supplements, painkillers, first-aid products and other OTC medicines. The Company's operates under brands such as PromoFarma, DoctiPharma, Apotal, Medpex and Teleclinic, among others
Employees
-
Trader
Investor
-
Global
-
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
9
Last Close Price
8.490CHF
Average target price
7.494CHF
Spread / Average Target
-11.73%

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!